Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Engl, B. Relja, Dana Marian, Christa Blumenberg, I. Müller, W. Beecken, Jon Jones, Eva Ringel, J. Bereiter-Hahn, D. Jonas, R. Blaheta (2006)
CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.Neoplasia, 8 4
O. Schmidt-Kittler, T. Ragg, A. Daskalakis, M. Granzow, A. Ahr, T. Blankenstein, M. Kaufmann, J. Diebold, H. Arnholdt, P. Müller, J. Bischoff, Detlev Harich, G. Schlimok, G. Riethmüller, R. Eils, C. Klein (2003)
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progressionProceedings of the National Academy of Sciences of the United States of America, 100
S. Deshmane, S. Kremlev, S. Amini, B. Sawaya (2009)
Monocyte chemoattractant protein-1 (MCP-1): an overview.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 29 6
J. Steiner, E. Murphy (2012)
Importance of chemokine (CC-motif) ligand 2 in breast cancerThe International Journal of Biological Markers, 27
J. Firth, B. Ebert, P. Ratcliffe (1995)
Hypoxic Regulation of Lactate Dehydrogenase AThe Journal of Biological Chemistry, 270
J. Campbell, A. Merkel, S. Masood-Campbell, Florent Elefteriou, J. Sterling (2012)
Models of bone metastasis.Journal of visualized experiments : JoVE, 67
H. Mellor, D. Ferguson, R. Callaghan (2005)
A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugsBritish Journal of Cancer, 93
Avital Mendelson, P. Frenette (2014)
Hematopoietic stem cell niche maintenance during homeostasis and regenerationNature Medicine, 20
T. Ueno, M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, M. Koike, Hidekuni Inadera, K. Matsushima (2000)
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 8
Eleonora Dondossola, Stephanie Alexander, B. Holzapfel, Stefano Filippini, M. Starbuck, R. Hoffman, N. Navone, E. De‐Juan‐Pardo, C. Logothetis, D. Hutmacher, P. Friedl (2018)
Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the boneScience Translational Medicine, 10
D. Schewe, J. Aguirre-Ghiso (2009)
Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy.Cancer research, 69 4
G. Fluegen, Álvaro Avivar-Valderas, Yarong Wang, Michael Padgen, J. Williams, A. Nobre, Verónica Calvo, Julie Cheung, J. Bravo-Cordero, D. Entenberg, J. Castracane, V. Verkhusha, P. Keely, J. Condeelis, J. Aguirre-Ghiso (2017)
Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironmentsNature Cell Biology, 19
Elina Azenshtein, G. Luboshits, S. Shina, E. Neumark, D. Shahbazian, M. Weil, N. Wigler, I. Keydar, A. Ben-Baruch (2002)
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.Cancer research, 62 4
J. Damiano, A. Cress, L. Hazlehurst, A. Shtil, W. Dalton (1999)
Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.Blood, 93 5
A. Reinisch, D. Hernandez, K. Schallmoser, R. Majeti (2017)
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into miceNature Protocols, 12
T. Schall, K. Bacon, Karen Toy, D. Goeddel (1990)
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 347
P. Croucher, M. McDonald, T. Martin (2016)
Bone metastasis: the importance of the neighbourhoodNature Reviews Cancer, 16
R. Coleman, H. Marshall, D. Cameron, D. Dodwell, R. Burkinshaw, M. Keane, M. Gil, S. Houston, R. Grieve, P. Barrett-Lee, D. Ritchie, J. Pugh, C. Gaunt, Una Rea, J. Peterson, C. Davies, V. Hiley, W. Gregory, R. Bell (2011)
Breast-cancer adjuvant therapy with zoledronic acid.The New England journal of medicine, 365 15
P Bragado, Y Estrada, F Parikh (2013)
TGF‐beta2 dictates disseminated tumour cell fate in target organs through TGF‐beta‐RIII and p38alpha/beta signalling, 15
Dominic Chow, L. Wenning, W. Miller, E. Papoutsakis (2001)
Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models.Biophysical journal, 81 2
Ekat Kritikou, A. Sharkey, K. Abell, P. Came, Elizabeth Anderson, R. Clarkson, C. Watson (2003)
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland, 130
Jd Firth, B. Ebert, C. Pugh, P. Ratcliffe (1994)
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.Proceedings of the National Academy of Sciences of the United States of America, 91 14
David Roberts (1996)
Regulation of tumor growth and metastasis by thrombospondin‐1The FASEB Journal, 10
A Reinisch, D Thomas, MR Corces (2016)
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells, 22
F. Balkwill (2004)
Cancer and the chemokine networkNature Reviews Cancer, 4
G. Dontu, W. Abdallah, J. Foley, Kyle Jackson, M. Clarke, M. Kawamura, M. Wicha (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.Genes & development, 17 10
R. Baron, S. Ferrari, R. Russell, R. Russell (2011)
Denosumab and bisphosphonates: different mechanisms of action and effects.Bone, 48 4
Miranda Sowder, Rachelle Johnson (2018)
Enrichment and detection of bone disseminated tumor cells in models of low tumor burdenScientific Reports, 8
A. Giatromanolaki, M. Koukourakis, C. Simopoulos, A. Polychronidis, K. Gatter, A. Harris, E. Sivridis (2004)
c-erbB-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α DependentClinical Cancer Research, 10
R. Coleman, P. Smith, R. Rubens (1998)
Clinical course and prognostic factors following bone recurrence from breast cancer.British Journal of Cancer, 77
C Li, DG Heidt, P Dalerba (2007)
Identification of pancreatic cancer stem cells, 67
Rachelle Johnson, A. Merkel, Jonathan Page, N. Ruppender, S. Guelcher, J. Sterling (2014)
Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancerClinical & Experimental Metastasis, 31
J. Ghiso, K. Kovalski, L. Ossowski (1999)
Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK SignalingThe Journal of Cell Biology, 147
Marco Montagner, E. Enzo, M. Forcato, Francesca Zanconato, A. Parenti, É. Rampazzo, G. Basso, G. Leo, A. Rosato, S. Bicciato, M. Cordenonsi, S. Piccolo (2012)
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factorsNature, 487
Suling Liu, G. Dontu, I. Mantle, Shivani Patel, N. Ahn, Kyle Jackson, Prerna Suri, M. Wicha (2006)
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.Cancer research, 66 12
J. Spencer, F. Ferraro, Emmanuel Roussakis, Alyssa Klein, Juwell Wu, J. Runnels, Walid Zaher, L. Mortensen, C. Alt, Raphaël Turcotte, R. Yusuf, D. Côté, S. Vinogradov, D. Scadden, Charles Lin (2014)
Direct measurement of local oxygen concentration in the bone marrow of live animalsNature, 508
A. Kobayashi, H. Okuda, F. Xing, P. Pandey, M. Watabe, S. Hirota, S. Pai, Wen Liu, K. Fukuda, C. Chambers, A. Wilber, K. Watabe (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in boneThe Journal of Experimental Medicine, 208
D. Liao, C. Corle, T. Seagroves, R. Johnson (2007)
Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.Cancer research, 67 2
C. Williams, Elizabeth Yeh, A. Soloff (2016)
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancyNPJ Breast Cancer, 2
M. Riihimäki, A. Hemminki, M. Fallah, H. Thomsen, K. Sundquist, K. Sundquist, J. Sundquist, J. Sundquist, K. Hemminki (2014)
Metastatic sites and survival in lung cancer.Lung cancer, 86 1
Yoshikazu Tsuzuki, D. Fukumura, Bert Oosthuyse, Chieko Koike, Peter Carmeliet, Rakesh Jain (2000)
Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.Cancer research, 60 22
Xin Lu, E. Mu, Yong Wei, S. Riethdorf, Qifeng Yang, Min Yuan, Jun-Hai Yan, Yuling Hua, Benjamin Tiede, Xuemin Lu, B. Haffty, K. Pantel, J. Massagué, Yibin Kang (2011)
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.Cancer cell, 20 6
P. Nowak‐Sliwinska, T. Segura, M. Iruela-Arispe (2014)
The chicken chorioallantoic membrane model in biology, medicine and bioengineeringAngiogenesis, 17
T. Martin (2016)
Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.Physiological reviews, 96 3
N. Almog, Lili Ma, R. Raychowdhury, C. Schwager, R. Erber, S. Short, L. Hlatky, P. Vajkoczy, P. Huber, J. Folkman, A. Abdollahi (2009)
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.Cancer research, 69 3
Promil Kukreja, A. Abdel‐Mageed, D. Mondal, Kai Liu, K. Agrawal (2005)
Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.Cancer research, 65 21
Stephen Robinson, K. Scott, Julia Wilson, Richard Thompson, A. Proudfoot, F. Balkwill (2003)
A chemokine receptor antagonist inhibits experimental breast tumor growth.Cancer research, 63 23
Rafael Fridman, G. Giaccone, T. Kanemoto, George Martin, A. Gazdar, J. Mulshine (1990)
Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.Proceedings of the National Academy of Sciences of the United States of America, 87 17
S. Tsutsui, K. Yasuda, Kosuke Suzuki, K. Tahara, H. Higashi, S. Era (2005)
Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.Oncology reports, 14 2
L. Suva, Charity Washam, R. Nicholas, R. Griffin (2011)
Bone metastasis: mechanisms and therapeutic opportunitiesNature Reviews Endocrinology, 7
H. Jørgensen, E. Allan, N. Jordanides, J. Mountford, T. Holyoake (2007)
Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells.Blood, 109 9
Joseph Vanderburgh, S. Guelcher, J. Sterling (2018)
3D bone models to study the complex physical and cellular interactions between tumor and the bone microenvironmentJournal of Cellular Biochemistry, 119
M. Al-Hajj, M. Wicha, Adalberto Benito-Hernández, S. Morrison, M. Clarke (2003)
Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 100
M. Delworth, K. Nishioka, C. Pettaway, M. Gutman, J. Killion, A. Voneschenbach, I. Fidler (1995)
Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, a new inhibitor of s-adenosylmethionine decarboxylase, produces cytostasis of human prostate-cancer in athymic nude-mice.International journal of oncology, 6 2
D. Liao, R. Johnson (2007)
Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 26
Cyrus Ghajar (2015)
Metastasis prevention by targeting the dormant nicheNature Reviews Cancer, 15
Cyrus Ghajar, H. Peinado, H. Mori, Irina Matei, K. Evason, H. Brazier, D. Almeida, A. Koller, K. Hajjar, D. Stainier, E. Chen, D. Lyden, M. Bissell (2013)
The perivascular niche regulates breast tumor dormancyNature cell biology, 15
B. Hillner (2000)
The role of bisphosphonates in metastatic breast cancer.Seminars in radiation oncology, 10 3
S. Käkönen, K. Selander, J. Chirgwin, J. Yin, S. Burns, W. Rankin, B. Grubbs, M. Dallas, Yong Cui, T. Guise (2002)
Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways*The Journal of Biological Chemistry, 277
M. Todaro, M. Alea, A. Stefano, P. Cammareri, L. Vermeulen, F. Iovino, C. Tripodo, A. Russo, G. Gulotta, J. Medema, G. Stassi (2007)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.Cell stem cell, 1 4
Rachelle Johnson, Yao Sun, Patricia Ho, Audrey Chan, Jasmine Johnson, N. Pavlos, Natalie Sims, T. Martin (2018)
Parathyroid Hormone-Related Protein Negatively Regulates Tumor Cell Dormancy Genes in a PTHR1/Cyclic AMP-Independent MannerFrontiers in Endocrinology, 9
A. Giatromanolaki, M. Koukourakis, C. Simopoulos, A. Polychronidis, K. Gatter, A. Harris, E. Sivridis (2004)
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.Clinical cancer research : an official journal of the American Association for Cancer Research, 10 23
Claire-Sophie Devignes, Yetki Aslan, A. Brenot, A. Devillers, K. Schepers, S. Fabre, J. Chou, A. Casbon, Z. Werb, S. Provot (2018)
HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in miceProceedings of the National Academy of Sciences, 115
R. Siegel, K. Miller, A. Jemal (2018)
Cancer statistics, 2018CA: A Cancer Journal for Clinicians, 68
N. Sims, andT. Martin (2015)
Coupling Signals between the Osteoclast and Osteoblast: How are Messages Transmitted between These Temporary Visitors to the Bone Surface?Frontiers in Endocrinology, 6
O. Sartor, R. Coleman, S. Nilsson, D. Heinrich, S. Helle, J. O’Sullivan, S. Fosså, A. Chodacki, P. Wiechno, J. Logue, A. Widmark, Dag Johannessen, P. Hoskin, N. James, A. Solberg, I. Syndikus, N. Vogelzang, C. O'Bryan-Tear, M. Shan, Ø. Bruland, C. Parker (2014)
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.The Lancet. Oncology, 15 7
N. Katakami, H. Kunikane, K. Takeda, K. Takayama, T. Sawa, H. Saito, M. Harada, S. Yokota, K. Ando, Yuko Saito, I. Yokota, Y. Ohashi, K. Eguchi (2014)
Prospective Study on the Incidence of Bone Metastasis (BM) and Skeletal-Related Events (SREs) in Patients (pts) with Stage IIIB and IV Lung Cancer—CSP-HOR 13Journal of Thoracic Oncology, 9
S. Paget (1989)
The distribution of secondary growths in cancer of the breast. 1889.Cancer metastasis reviews, 8 2
R. Taichman, Lalit Patel, Rachel Bedenis, Jingcheng Wang, S. Weidner, Taibriana Schumann, K. Yumoto, J. Berry, Y. Shiozawa, K. Pienta (2013)
GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor FormationPLoS ONE, 8
T. Hiraga, S. Kizaka-Kondoh, K. Hirota, M. Hiraoka, T. Yoneda (2007)
Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.Cancer research, 67 9
A Lipton, RL Theriault, GN Hortobagyi (2000)
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow‐up of two randomized, placebo‐controlled trials, 88
C. Wong, Huafeng Zhang, Daniele Gilkes, Jasper Chen, Hong Wei, P. Chaturvedi, Maimon Hubbi, G. Semenza (2012)
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasisJournal of Molecular Medicine, 90
K. Bussard, D. Venzon, A. Mastro (2010)
Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancerJournal of Cellular Biochemistry, 111
Carine Chavey, F. Bibeau, S. Gourgou-Bourgade, Sandrine Burlinchon, F. Boissiere, D. Laune, S. Roques, G. Lazennec (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine contentBreast Cancer Research, 9
A. Müller, B. Homey, H. Soto, Nianfeng Ge, D. Catron, Matthew Buchanan, T. Mcclanahan, E. Murphy, W. Yuan, S. Wagner, J. Barrera, A. Mohar, E. Verástegui, A. Zlotnik (2001)
Involvement of chemokine receptors in breast cancer metastasisNature, 410
S. Pece, D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi, S. Ronzoni, L. Bernard, G. Viale, P. Pelicci, P. Fiore (2010)
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 140
A. Lipton, R. Theriault, G. Hortobagyi, Joseph Simeone, Robert Knight, K. Mellars, D. Reitsma, M. Heffernan, J. Seaman (2000)
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastasesCancer, 88
Rachelle Johnson, Miranda Sowder, A. Giaccia (2017)
Hypoxia and Bone Metastatic DiseaseCurrent Osteoporosis Reports, 15
Michael Li, R. Pathak, E. López-Rivera, S. Friedman, J. Aguirre-Ghiso, A. Sikora (2015)
The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.Journal of visualized experiments : JoVE, 104
Shenduo Li, M. Kennedy, Sturgis Payne, Kelly Kennedy, V. Seewaldt, S. Pizzo, R. Bachelder (2014)
Model of Tumor Dormancy/Recurrence after Short-Term ChemotherapyPLoS ONE, 9
F. Arai, A. Hirao, M. Ohmura, Hidetaka Sato, S. Matsuoka, K. Takubo, Keisuke Ito, G. Koh, T. Suda (2004)
Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow NicheCell, 118
J. Erler, A. Giaccia (2006)
Lysyl oxidase mediates hypoxic control of metastasis.Cancer research, 66 21
Guang-lei Wang, B. Jiang, E. Rue, G. Semenza (1995)
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences of the United States of America, 92 12
M. Copland, A. Hamilton, Lucy Elrick, J. Baird, E. Allan, N. Jordanides, M. Barow, J. Mountford, T. Holyoake (2006)
Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction.Blood, 107 11
E. Adler, Charles Lemken, Nicholas Katchen, R. Kurt (2003)
A dual role for tumor-derived chemokine RANTES (CCL5).Immunology letters, 90 2-3
J. Aguirre-Ghiso (2007)
Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 7
Lei Ding, T. Saunders, G. Enikolopov, S. Morrison (2011)
Endothelial and perivascular cells maintain haematopoietic stem cellsNature, 481
J. Wyckoff, Yarong Wang, E. Lin, Jiu-feng Li, S. Goswami, E. Stanley, J. Segall, J. Pollard, J. Condeelis (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.Cancer research, 67 6
J. Erler, K. Bennewith, Monica Nicolau, N. Dornhöfer, C. Kong, Q. Le, Jen-Tsan Chi, S. Jeffrey, A. Giaccia (2006)
Lysyl oxidase is essential for hypoxia-induced metastasisNature, 440
J. Erler, K. Bennewith, T. Cox, G. Lang, D. Bird, A. Koong, Q. Le, A. Giaccia (2009)
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.Cancer cell, 15 1
M. Sakai, H. Kato, A. Sano, N. Tanaka, Takanori Inose, H. Kimura, M. Sohda, M. Nakajima, H. Kuwano (2009)
Expression of Lysyl Oxidase Is Correlated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 16
M. Sosa, F. Parikh, A. Maia, Y. Estrada, Almudena Bosch, P. Bragado, Esther Ekpin, Ajish George, Yang-Yu Zheng, Hung-Ming Lam, C. Morrissey, C. Chung, E. Farias, E. Bernstein, J. Aguirre-Ghiso (2014)
NR2F1 controls tumor cell dormancy via SOX9 and RARβ driven quiescence programsNature communications, 6
G. Roodman (2004)
Mechanisms of bone metastasis.Discovery medicine, 4 22
M. Balić, Henry Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. Datar, R. Cote (2006)
Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell PhenotypeClinical Cancer Research, 12
Karobi Moitra, H. Lou, Michael Dean (2011)
Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic DevelopmentClinical Pharmacology & Therapeutics, 89
Miguel Martín, R. Bell, H. Bourgeois, A. Brufsky, I. Diel, A. Eniu, L. Fallowfield, Y. Fujiwara, J. Jassem, A. Paterson, D. Ritchie, G. Steger, A. Stopeck, C. Vogel, M. Fan, Q. Jiang, K. Chung, R. Dansey, A. Braun (2012)
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic AcidClinical Cancer Research, 18
Xiaoxian Li, M. Lewis, Jian Huang, C. Gutierrez, C. Osborne, Meng-Fen Wu, S. Hilsenbeck, A. Pavlick, Xiaomei Zhang, G. Chamness, H. Wong, J. Rosen, Jenny Chang (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.Journal of the National Cancer Institute, 100 9
A. Fernandis, A. Prasad, H. Band, R. Kloesel, R. Ganju (2004)
Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cellsOncogene, 23
D. Good, Peter POLVERINIt, F. Rastinejad, M. Beau, R. Lemons, A. William, Frazier, N. Bouck (1990)
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.Proceedings of the National Academy of Sciences of the United States of America, 87 17
G. Roodman, R. Silbermann (2015)
Mechanisms of osteolytic and osteoblastic skeletal lesions.BoneKEy reports, 4
Huayue Chen, T. Senda, K. Kubo (2015)
The osteocyte plays multiple roles in bone remodeling and mineral homeostasisMedical Molecular Morphology, 48
A. Reinisch, Daniel Thomas, M. Corces, Xiaohua Zhang, D. Gratzinger, W. Hong, K. Schallmoser, D. Strunk, R. Majeti (2016)
A Humanized Ossicle-niche Xenotransplantation Model Enables Improved Human Leukemic EngraftmentNature medicine, 22
F. Röhrig, Sandra Vorlová, H. Hoffmann, Martin Wartenberg, Freddy Escorcia, S. Keller, M. Tenspolde, I. Weigand, Sabine Gätzner, Katia Manova, Olaf Penack, D. Scheinberg, Andreas Rosenwald, Süleyman Ergün, Z. Granot, E. Henke (2016)
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumorsOncogene, 36
T. Sethi, R. Rintoul, S. Moore, A. MacKinnon, D. Salter, C. Choo, E. Chilvers, I. Dransfield, S. Donnelly, R. Strieter, C. Haslett (1999)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 5
R. Gomis, S. Gawrzak (2017)
Tumor cell dormancyMolecular Oncology, 11
G. Soria, A. Ben-Baruch (2008)
The inflammatory chemokines CCL2 and CCL5 in breast cancer.Cancer letters, 267 2
S. Eblen, M. Fautsch, R. Anders, E. Leof (1995)
Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 6 8
Yang Liu, Xuetao Cao (2016)
Characteristics and Significance of the Pre-metastatic Niche.Cancer cell, 30 5
S. Biswas, J. Nyman, JoAnn Alvarez, A. Chakrabarti, Austin Ayres, J. Sterling, J. Edwards, Tapasi Rana, Rachelle Johnson, D. Perrien, S. Lonning, Y. Shyr, L. Matrisian, G. Mundy (2011)
Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to BonePLoS ONE, 6
P. Goss, A. Chambers (2010)
Does tumour dormancy offer a therapeutic target?Nature Reviews Cancer, 10
D. Javelaud, K. Mohammad, C. McKenna, Pierrick Fournier, F. Luciani, M. Niewolna, J. André, V. Delmas, L. Larue, T. Guise, A. Mauviel (2007)
Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.Cancer research, 67 5
R. Korah, M. Boots, R. Wieder (2004)
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer CellsCancer Research, 64
Dahu Chen, Yutong Sun, Yongkun Wei, Peijing Zhang, A. Rezaeian, J. Teruya-Feldstein, Sumeet Gupta, Han Liang, Hui-Kuan Lin, M. Hung, Li Ma (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic markerNature Medicine, 18
S. Bao, Qiulian Wu, R. McLendon, Y. Hao, Q. Shi, A. Hjelmeland, M. Dewhirst, D. Bigner, J. Rich (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 444
S. Gawrzak, Lorenzo Rinaldi, S. Gregorio, E. Arenas, F. Salvador, J. Urosevic, Cristina Figueras-Puig, F. Rojo, Ivan Barrantes, J. Cejalvo, M. Palafox, M. Guiu, A. Berenguer-Llergo, Aikaterini Symeonidi, A. Bellmunt, Daniela Kalafatovic, Anna Arnal-Estapé, Esther Fernandez, Barbara Müllauer, Rianne Groeneveld, Konstantin Slobodnyuk, C. Attolini, C. Saura, J. Arribas, J. Cortés, A. Rovira, M. Muñoz, A. Lluch, V. Serra, J. Albanell, A. Prat, A. Nebreda, S. Benitah, R. Gomis (2018)
MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancerNature Cell Biology, 20
S. Bliss, G. Sinha, Oleta Sandiford, L. Williams, Daniel Engelberth, Khadidiatou Guiro, L. Isenalumhe, Steven Greco, Seda Ayer, M. Bryan, Rakesh Kumar, N. Ponzio, P. Rameshwar (2016)
Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow.Cancer research, 76 19
M. Kinder, Elizabeth Chislock, K. Bussard, Laurie Shuman, A. Mastro (2008)
Metastatic breast cancer induces an osteoblast inflammatory response.Experimental cell research, 314 1
D. Barkan, Jeffrey Green, A. Chambers (2010)
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.European journal of cancer, 46 7
Jianhua Wang, R. Loberg, R. Taichman (2007)
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasisCancer and Metastasis Reviews, 25
A. Ranganathan, Lin Zhang, A. Adam, J. Aguirre-Ghiso (2006)
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.Cancer research, 66 3
Hai Wang, Cuijuan Yu, Xia Gao, T. Welte, A. Muscarella, Lin Tian, Hong Zhao, Z. Zhao, Z. Zhao, Shi-Yu Du, Jianning Tao, Brendan Lee, Thomas Westbrook, Stephen Wong, Xin Jin, J. Rosen, C. Osborne, X. Zhang (2015)
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.Cancer cell, 27 2
DC Chow, LA Wenning, WM Miller, ET Papoutsakis (2001)
Modeling pO(2) distributions in the bone marrow hematopoietic compartment, 81
A. Resovi, D. Pinessi, G. Chiorino, G. Taraboletti (2014)
Current understanding of the thrombospondin-1 interactome.Matrix biology : journal of the International Society for Matrix Biology, 37
M. Rogers, Katherine Novak, D. Zurakowski, L. Cryan, A. Blois, E. Lifshits, T. Bø, A. Oyan, Elise Bender, Michael Lampa, Soo-Young Kang, K. Naxerova, K. Kalland, O. Straume, L. Akslen, R. Watnick, J. Folkman, G. Naumov (2014)
Spontaneous Reversion of the Angiogenic Phenotype to a Nonangiogenic and Dormant State in Human TumorsMolecular Cancer Research, 12
Y. Hao, Raju Reddy, Sae-Hong Lee, Jami Milam, Chung Owyang, M. DiMagno (2005)
DEPLETION OF HEAT SHOCK PROTEIN-70 (HSP70) CAUSES APOPTOSIS IN PANCREATIC CANCER CELLSPancreas, 31
N. Almog, Lili Ma, C. Schwager, Bastian Brinkmann, Afshin Beheshti, P. Vajkoczy, J. Folkman, L. Hlatky, A. Abdollahi (2012)
Consensus Micro RNAs Governing the Switch of Dormant Tumors to the Fast-Growing Angiogenic PhenotypePLoS ONE, 7
Ning Wang, Freyja Docherty, H. Brown, K. Reeves, A. Fowles, M. Lawson, P. Ottewell, I. Holen, P. Croucher, C. Eaton (2015)
Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis‐initiating cells in prostate cancerThe FASEB Journal, 29
Rachelle Johnson, E. Schipani, A. Giaccia (2015)
HIF targets in bone remodeling and metastatic disease.Pharmacology & therapeutics, 150
B. Shemirani, D. Crowe (2002)
Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.Oral oncology, 38 3
R. Coleman, D. Cameron, D. Dodwell, R. Bell, Caroline Wilson, E. Rathbone, M. Keane, M. Gil, R. Burkinshaw, R. Grieve, P. Barrett-Lee, D. Ritchie, Victoria Liversedge, S. Hinsley, H. Marshall (2014)
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.The Lancet. Oncology, 15 9
R. Coleman, M. Gnant, G. Morgan, P. Clézardin (2012)
Effects of bone-targeted agents on cancer progression and mortality.Journal of the National Cancer Institute, 104 14
M. Diehn, Robert Cho, N. Lobo, T. Kalisky, M. Dorie, A. Kulp, D. Qian, Jessica Lam, Laurie Ailles, Manzhi Wong, Benzion Joshua, Michael Kaplan, I. Wapnir, F. Dirbas, G. Somlo, C. Garberoglio, B. Paz, Jeannie Shen, Sean Lau, Stephen Quake, J. Brown, Irving Weissman, Michael Clarke (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 458
MS Sosa, F Parikh, AG Maia (2015)
NR2F1 controls tumour cell dormancy via SOX9‐ and RARbeta‐driven quiescence programmes, 6
B. Leder (2017)
Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis TherapyCurrent Osteoporosis Reports, 15
Lei Xiang, Zhi-heng Liu, Q. Huan, P. Su, Guang-Jun Du, Yan Wang, P. Gao, Geng-yin Zhou (2012)
Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinomaDiagnostic Pathology, 7
Lauren Dunn, K. Mohammad, Pierrick Fournier, C. McKenna, Holly Davis, M. Niewolna, X. Peng, J. Chirgwin, T. Guise (2009)
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone MicroenvironmentPLoS ONE, 4
M. Gnant, B. Mlineritsch, W. Schippinger, G. Luschin-Ebengreuth, S. Pöstlberger, C. Menzel, R. Jakesz, M. Seifert, M. Hubalek, V. Bjelic-Radisic, H. Samonigg, C. Tausch, H. Eidtmann, G. Steger, W. Kwasny, P. Dubsky, M. Fridrik, F. Fitzal, M. Stierer, E. Ruecklinger, R. Greil, C. Marth (2009)
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.The New England journal of medicine, 360 7
B. Bao, Aamir Ahmad, A. Azmi, Shadan Ali, F. Sarkar (2013)
Overview of Cancer Stem Cells (CSCs) and Mechanisms of Their Regulation: Implications for Cancer TherapyCurrent Protocols in Pharmacology, 61
Rachelle Johnson, Elizabeth Finger, M. Olcina, M. Vilalta, T. Aguilera, Y. Miao, A. Merkel, Joshua Johnson, J. Sterling, Joy Wu, A. Giaccia (2016)
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrowNature cell biology, 18
L. Ricci-Vitiani, D. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, R. Maria (2007)
Identification and expansion of human colon-cancer-initiating cellsNature, 445
J. Sot, S. Scheuring, R. Pochampally, Y. Shiozawa, E. White, A. Ryazanov, B. Palsson, I. Tikhonova, H. Jewhurst, Jan Dvorak, M. Robinson, Krystyna Cwiklinski (2016)
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone *The Journal of Biological Chemistry, 291
P. Branemark (1961)
Experimental Investigation of Microcirculation in Bone MarrowAngiology, 12
C. Parker, R. Coleman, O. Sartor, N. Vogelzang, D. Bottomley, D. Heinrich, S. Helle, J. O’Sullivan, S. Fosså, A. Chodacki, P. Wiechno, J. Logue, M. Seke, A. Widmark, D. Johannessen, P. Hoskin, N. James, A. Solberg, I. Syndikus, J. Kliment, S. Wedel, S. Boehmer, M. Dall'oglio, L. Franzén, Ø. Bruland, O. Petrenciuc, K. Staudacher, Rui Li, S. Nilsson (2017)
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.European urology
J. Yin, K. Selander, J. Chirgwin, M. Dallas, B. Grubbs, R. Wieser, J. Massagué, G. Mundy, T. Guise (1999)
TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.The Journal of clinical investigation, 103 2
Xi-wei Ding, Junhua Wu, Chunping Jiang (2010)
ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.Life sciences, 86 17-18
Anjali Kusumbe, Saravana Ramasamy, R. Adams (2014)
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in boneNature, 507
Salvatore Coniglio (2018)
Role of Tumor-Derived Chemokines in Osteolytic Bone MetastasisFrontiers in Endocrinology, 9
G. Naumov, I. Macdonald, P. Weinmeister, N. Kerkvliet, Kishore Nadkarni, Sylvia Wilson, V. Morris, A. Groom, A. Chambers (2002)
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.Cancer research, 62 7
P. Bragado, Y. Estrada, M. Sosa, Álvaro Avivar-Valderas, D. Cannan, E. Genden, M. Teng, A. Ranganathan, H. Wen, A. Kapoor, E. Bernstein, J. Aguirre-Ghiso (2012)
Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating PropertiesPLoS ONE, 7
P. Bragado, Y. Estrada, F. Parikh, S. Krause, Carla Capobianco, H. Farina, D. Schewe, J. Aguirre-Ghiso (2013)
TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signallingNature cell biology, 15
Kentaro Nobutani, Y. Shimono, Kiyohito Mizutani, Yuki Ueda, Toshihiro Suzuki, Midori Kitayama, A. Minami, K. Momose, K. Miyawaki, K. Akashi, T. Azuma, Y. Takai (2015)
Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their DormancyPLoS ONE, 10
R. Korah, M. Boots, R. Wieder (2004)
Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.Cancer research, 64 13
H. Taipaleenmäki, G. Browne, Jacqueline Akech, J. Zustin, A. Wijnen, J. Stein, E. Hesse, G. Stein, J. Lian (2015)
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.Cancer research, 75 7
S. Danilin, A. Merkel, Joshua Johnson, Rachelle Johnson, J. Edwards, J. Sterling (2012)
Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destructionOncoimmunology, 1
Junlin Shi, Lihui Wang, C. Zou, Y. Xia, Siyuan Qin, E. Keller, A. Mizokami, Jian Zhang, Yi Lu (2018)
Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathwayOncotarget, 9
T. Schatton, G. Murphy, N. Frank, K. Yamaura, A. Waaga-Gasser, M. Gasser, Q. Zhan, Stefan Jordan, L. Duncan, C. Weishaupt, R. Fuhlbrigge, T. Kupper, M. Sayegh, M. Frank (2008)
Identification of cells initiating human melanomasNature, 451
R. Kaplan, R. Riba, S. Zacharoulis, Anna Bramley, L. Vincent, Carla Costa, Daniel MacDonald, D. Jin, K. Shido, Scott Kerns, Zhen-ping Zhu, D. Hicklin, Yan Wu, J. Port, N. Altorki, Elisa Port, D. Ruggero, S. Shmelkov, Kristian Jensen, S. Rafii, D. Lyden (2005)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheNature, 438
C. Morrissey, M. Roudier, Alexander Dowell, L. True, Melanie Ketchanji, C. Welty, E. Corey, P. Lange, C. Higano, R. Vessella (2013)
Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration‐resistant prostate cancer: Results from the University of Washington Rapid Autopsy SeriesJournal of Bone and Mineral Research, 28
T. Engl, B. Relja, Dana Marian, Christa Blumenberg, I. Müller, W. Beecken, Jon Jones, Eva Ringel, J. Bereiter-Hahn, D. Jonas, R. Blaheta (2006)
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 IntegrinsNeoplasia, 8
M. Banyś, A. Hartkopf, N. Krawczyk, T. Kaiser, F. Meier-Stiegen, T. Fehm, H. Neubauer (2012)
Dormancy in breast cancer.Breast cancer, 4
Yves Hüsemann, J. Geigl, Falk Schubert, P. Musiani, M. Meyer, E. Burghart, G. Forni, R. Eils, T. Fehm, G. Riethmüller, C. Klein (2008)
Systemic spread is an early step in breast cancer.Cancer cell, 13 1
K. Gustafsson, H. Farman, P. Henning, V. Lionikaite, S. Movérare-Skrtic, J. Wu, H. Ryberg, A. Koskela, J. Gustafsson, J. Tuukkanen, E. Levin, C. Ohlsson, M. Lagerquist (2016)
The role of membrane ERα signaling in bone and other major estrogen responsive tissuesScientific Reports, 6
G. Richardson, C. Robson, S. Lang, D. Neal, N. Maitland, A. Collins (2004)
CD133, a novel marker for human prostatic epithelial stem cellsJournal of Cell Science, 117
(2018)
PTHR 1 / cyclic AMP ‐ independent manner
CHRISTINE Horak, JONG Lee, JEAN‐CLAUDE Marshall, S. Shreeve, Patricia Steeg (2008)
The role of metastasis suppressor genes in metastatic dormancyAPMIS, 116
Hongli Zhao, Liyuan Guo, Hong Zhao, Jiaxin Zhao, H. Weng, Bin Zhao (2014)
CXCR4 over-expression and survival in cancer: A system review and meta-analysisOncotarget, 6
Shaheen Sikandar, Kira Pate, S. Anderson, Diana Dizon, R. Edwards, M. Waterman, S. Lipkin (2010)
NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer.Cancer research, 70 4
E. Iorns, T. Ward, S. Dean, A. Jegg, Dafydd Thomas, N. Murugaesu, D. Sims, C. Mitsopoulos, K. Fenwick, I. Kozarewa, C. Naceur-Lombarelli, M. Zvelebil, C. Isacke, C. Lord, A. Ashworth, H. Hnatyszyn, M. Pegram, M. Lippman (2012)
Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressorBreast Cancer Research and Treatment, 135
Y. Guan, B. Gerhard, D. Hogge (2003)
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).Blood, 101 8
J. Harrison, P. Rameshwar, V. Chang, P. Bandari (2002)
Oxygen saturation in the bone marrow of healthy volunteers.Blood, 99 1
D. Weinstat-Saslow, V. Zabrenetzky, Kenneth VanHoutte, W. Frazier, D. Roberts, P. Steeg (1994)
Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.Cancer research, 54 24
R. Clarke, Katherine Spence, E. Anderson, A. Howell, H. Okano, C. Potten (2005)
A putative human breast stem cell population is enriched for steroid receptor-positive cells.Developmental biology, 277 2
N. Almog, Vanessa Henke, Ludmila Flores, L. Hlatky, A. Kung, R. Wright, R. Berger, L. Hutchinson, G. Naumov, Elise Bender, L. Akslen, E. Achilles, J. Folkman, E. Achilles (2006)
Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesisThe FASEB Journal, 20
M. Bienz, F. Saad (2015)
Management of bone metastases in prostate cancer: a reviewCurrent Opinion in Supportive and Palliative Care, 9
H. Saji, M. Koike, T. Yamori, S. Saji, M. Seiki, K. Matsushima, M. Toi (2001)
Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinomaCancer, 92
D. Shweiki, A. Itin, D. Soffer, E. Keshet (1992)
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 359
P. Major, R. Cook, A. Lipton, Matthew Smith, E. Terpos, R. Coleman (2009)
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidityBMC Cancer, 9
Minji Jo, B. Eastman, Drue Webb, K. Stoletov, R. Klemke, S. Gonias (2010)
Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.Cancer research, 70 21
E. Andrews, A. Gilsenan, K. Midkiff, B. Sherrill, Yun Wu, B. Mann, D. Masica (2012)
The US Postmarketing Surveillance Study of Adult Osteosarcoma and Teriparatide: Study Design and Findings From the First 7 YearsJournal of Bone and Mineral Research, 27
J. Dales, S. Garcia, S. Meunier-Carpentier, L. Andrac‐Meyer, O. Haddad, M. Lavaut, C. Allasia, P. Bonnier, C. Charpin (2005)
Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patientsInternational Journal of Cancer, 116
Shailesh Singh, U. Singh, W. Grizzle, J. Lillard (2004)
CXCL12–CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasionLaboratory Investigation, 84
Xin Lu, C. Yan, Min Yuan, Yong Wei, G. Hu, Yibin Kang (2010)
In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer.Cancer research, 70 10
Y. Shiozawa, E. Pedersen, Lalit Patel, A. Ziegler, Aaron Havens, Younghun Jung, Jingcheng Wang, Stephanie Zalucha, R. Loberg, K. Pienta, R. Taichman (2010)
GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.Neoplasia, 12 2
G. Dunn, L. Old, R. Schreiber (2004)
The immunobiology of cancer immunosurveillance and immunoediting.Immunity, 21 2
O. Straume, T. Shimamura, Michael Lampa, J. Carretero, A. Øyan, Di Jia, Christa Borgman, Margaret Soucheray, S. Downing, S. Short, Soo-Young Kang, Souming Wang, Liang Chen, K. Collett, Ingeborg Bachmann, Kwok-kin Wong, G. Shapiro, K. Kalland, J. Folkman, R. Watnick, L. Akslen, G. Naumov (2012)
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancerProceedings of the National Academy of Sciences, 109
N. Ruppender, N. Ruppender, A. Merkel, T. Martin, G. Mundy, J. Sterling, S. Guelcher, S. Guelcher (2010)
Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer CellsPLoS ONE, 5
D. Hambardzumyan, O. Becher, M. Rosenblum, P. Pandolfi, K. Manova-Todorova, E. Holland (2008)
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.Genes & development, 22 4
Usman Khan, S. Hashimi, Mahmoud Bakr, M. Forwood, N. Morrison (2016)
CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant CellsJournal of Cellular Biochemistry, 117
Jonathan Gleadle, Peter Ratcliffe (1997)
Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase.Blood, 89 2
R. Coleman (2006)
Clinical Features of Metastatic Bone Disease and Risk of Skeletal MorbidityClinical Cancer Research, 12
D. Liao, C. Corle, T. Seagroves, R. Johnson (2007)
Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and ProgressionCancer Research, 67
K. Yumoto, Matthew Eber, Jingcheng Wang, Frank Cackowski, A. Decker, Eunsohl Lee, A. Nobre, J. Aguirre-Ghiso, Younghun Jung, R. Taichman (2016)
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrowScientific Reports, 6
Q. Le, J. Harris, A. Magliocco, C. Kong, R. Diaz, B. Shin, H. Cao, A. Trotti, J. Erler, C. Chung, A. Dicker, T. Pajak, A. Giaccia, K. Ang (2009)
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 26
J. Sterling, B. Oyajobi, B. Grubbs, S. Padalecki, S. Munoz, Anjana Gupta, B. Story, Ming Zhao, G. Mundy (2006)
The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.Cancer research, 66 15
S. Dieter, C. Ball, Christopher Hoffmann, A. Nowrouzi, F. Herbst, O. Zavidij, U. Abel, A. Arens, W. Weichert, K. Brand, M. Koch, J. Weitz, M. Schmidt, C. Kalle, H. Glimm (2011)
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.Cell stem cell, 9 4
Vanessa Thompson, Tanya Day, T. Bianco-Miotto, L. Selth, Guangzhou Han, Mervyn Thomas, Grant Buchanan, H. Scher, C. Nelson, N. Greenberg, L. Butler, W. Tilley (2012)
A gene signature identified using a mouse model of androgen receptor‐dependent prostate cancer predicts biochemical relapse in human diseaseInternational Journal of Cancer, 131
K. Mohammad, D. Javelaud, D. Javelaud, Pierrick Fournier, M. Niewolna, M. Niewolna, C. McKenna, X. Peng, X. Peng, V. Dương, Lauren Dunn, A. Mauviel, A. Mauviel, T. Guise (2011)
TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases.Cancer research, 71 1
L. Boix, J. López-Oliva, A. Rhodes, J. Bruix (2016)
Restoring miR122 in human stem-like hepatocarcinoma cells, prompts tumor dormancy through Smad-independent TGF-β pathwayOncotarget, 7
F. Hillen, A. Griffioen (2007)
Tumour vascularization: sprouting angiogenesis and beyondCancer Metastasis Reviews, 26
B. Muz, P. Puente, F. Azab, A. Azab (2015)
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapyHypoxia, 3
B. Ebert, J. Firth, P. Ratcliffe (1995)
Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*)The Journal of Biological Chemistry, 270
L. D’Amico, S. Mahajan, A. Capietto, Zhengfeng Yang, Aliyeh Zamani, Biancamaria Ricci, D. Bumpass, M. Meyer, X. Su, A. Wang-Gillam, K. Weilbaecher, S. Stewart, D. DeNardo, R. Faccio (2016)
Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancerThe Journal of Experimental Medicine, 213
B. Bidwell, C. Slaney, N. Withana, S. Forster, Yuan Cao, S. Loi, D. Andrews, T. Mikeska, Niamh Mangan, S. Samarajiwa, N. Weerd, J. Gould, P. Argani, A. Möller, M. Smyth, Robin Anderson, P. Hertzog, B. Parker (2012)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escapeNature Medicine, 18
M. Haider, H. Taipaleenmäki (2018)
Targeting the Metastatic Bone Microenvironment by MicroRNAsFrontiers in Endocrinology, 9
Rachel Thomas, T. Guise, J. Yin, J. Elliott, N. Horwood, T. Martin, M. Gillespie (1999)
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1.Endocrinology, 140 10
M. Roudier, C. Morrissey, L. True, C. Higano, R. Vessella, S. Ott (2008)
Histopathological assessment of prostate cancer bone osteoblastic metastases.The Journal of urology, 180 3
V. Weaver, S. Lelièvre, J. Lakins, M. Chrenek, Jonathan Jones, F. Giancotti, Z. Werb, M. Bissell (2002)
beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.Cancer cell, 2 3
Christian Thomas, C. Wiesner, S. Melchior, F. Schmidt, R. Gillitzer, J. Thüroff, J. Pfitzenmaier (2009)
Urokinase‐plasminogen‐activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancerBJU International, 104
JD Firth, BL Ebert, PJ Ratcliffe (1995)
Hypoxic regulation of lactate dehydrogenase a. Interaction between hypoxia‐inducible factor 1 and cAMP response elements, 270
Stacey Butler, Lisa Richardson, N. Farias, J. Morrison, B. Coomber (2017)
Characterization of cancer stem cell drug resistance in the human colorectal cancer cell lines HCT116 and SW480.Biochemical and biophysical research communications, 490 1
P. Sansone, C. Savini, I. Kurelac, Q. Chang, Laura Amato, A. Strillacci, Anna Stepanova, L. Iommarini, C. Mastroleo, L. Daly, A. Galkin, B. Thakur, Nadine Soplop, K. Uryu, Ayuko Hoshino, L. Norton, M. Bonafè, M. Cricca, G. Gasparre, D. Lyden, J. Bromberg (2017)
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancerProceedings of the National Academy of Sciences of the United States of America, 114
J. Bergh, K. Pritchard, K. Albain, S. Anderson, R. Arriagada, W. Barlow, W. Bergsten-Nordström, J. Bliss, F. Boccardo, R. Bradley, M. Buyse, D. Cameron, M. Clarke, M. Coates, R. Coleman, C. Correa, J. Costantino, J. Cuzick, N. Davidson, C. Davies, A. Leo, M. Dowsett, M. Ewertz, J. Forbes, R. Gelber, R. Geyer, R. Gianni, M. Gnant, A. Goldhirsch, R. Gray, D. Hayes, C. Hill, J. Ingle, W. Janni, E. Mackinnon, M. Martin, P. Mcgale, L. Norton, Y. Ohashi, S. Paik, H. Pan, E. Perez, R. Peto, R. Piccart, L. Pierce, V. Raina, P. Ravdin, J. Robertson, E. Rutgers, J. Sparano, S. Swain, Carolyn Taylor, G. Viale, G. Minckwitz, Xiang Wang, T. Whelan, N. Wilcken, E. Winer, N. Wolmark, W. Wood (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trialsThe Lancet, 386
R. Coleman, R. Boer, H. Eidtmann, A. Llombart, N. Davidson, P. Neven, G. Minckwitz, H. Sleeboom, J. Forbes, C. Barrios, A. Frassoldati, I. Campbell, O. Paija, N. Martin, A. Modi, N. Bundred (2013)
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.Annals of oncology : official journal of the European Society for Medical Oncology, 24 2
Dominic Chow, L. Wenning, W. Miller, E. Papoutsakis (2001)
Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model.Biophysical journal, 81 2
Rachelle Johnson, M. Nguyen, S. Padalecki, B. Grubbs, A. Merkel, B. Oyajobi, L. Matrisian, G. Mundy, J. Sterling (2011)
TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.Cancer research, 71 3
S. Junankar, G. Shay, Julie Jurczyluk, Naveid Ali, J. Down, N. Pocock, A. Parker, A. Nguyen, Shuting Sun, B. Kashemirov, C. McKenna, P. Croucher, A. Swarbrick, K. Weilbaecher, T. Phan, M. Rogers (2015)
Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer.Cancer discovery, 5 1
GN Naumov, J Folkman, O Straume, LA Akslen (2008)
Tumor‐vascular interactions and tumor dormancy, 116
A. Dasgupta, Andrea Lim, Cyrus Ghajar (2017)
Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Molecular Oncology, 11
Cancer Reports – Wiley
Published: Feb 1, 2020
Keywords: ; ; ; ; ;
You can share this free article with as many people as you like with the url below! We hope you enjoy this feature!
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.